Black Diamond Therapeutics

Black Diamond is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2020
Stage of Initial Investment
Series B
Initial Investment Year
2018
Black Diamond Portco Hover Image